Object. Seizures are the most common presenting symptom of supratentorial cerebral cavernous malformations (CCMs) and progress to medically refractory epilepsy in 40% of patients. Predictors of seizure freedom in the resection of CCMs are incompletely understood.
C erebral cavernous malformations are endothelial-lined vascular malformations composed of dilated sinusoids filled with blood and no intervening brain tissue and may be associated with intracranial hemorrhage. 4, 39, 42 Seizures, the most common presenting symptom of supratentorial CCMs, are thought to arise from the excitotoxic effects of blood products on perilesional parenchyma. [52] [53] [54] Overall, epilepsy affects 35%-70% of patients with CCMs, with approximately 40% of individuals progressing to medically refractory epilepsy. 13, 37, 44 It is well known that epilepsy can dramatically diminish quality of life with serious morbidity and that AEDs frequently have unfavorable side-effect profiles. 10, 18, 46 Therefore, while most authors examining the natural history and treatment of CCMs focus on the risk of intracranial hemorrhage, 34, 39, 41 abolishing seizures is an important and often underappreciated treatment goal in managing these lesions.
Factors associated with seizure control in the resection of supratentorial CCMs remain incompletely understood as a result of patient diversity, small sample sizes, and disagreement about operative approaches. For instance, there is controversy regarding whether excision of the hemosiderin-stained parenchymal ring typically surrounding CCMs is necessary to achieve seizure freedom 6, 7, 28, 49, 56, 57 and whether an expedited surgical approach predicts improved seizure outcome. 1, 8, 14 Neither is it fully understood how the preoperative seizure profile might predict postoperative seizure recurrence. 13, 37 The systematic consolidation and analysis of predictors of seizure freedom as reported across various smaller studies may help to clarify these issues.
Our goal was to perform a quantitative and comprehensive systematic literature review of seizure outcomes following the resection of supratentorial CCMs associated with seizures. We analyzed the proportion of patients in whom complete seizure freedom was achieved after surgery, and we stratified outcomes according to several potential prognostic variables.
Methods

Article Selection and Data Extraction
We conducted a PubMed search of articles published between 1985 and February 2011 by using the following search terms alone and in combination: "seizure," "epilepsy," "cavernous malformation," "cavernous angioma," "cavernous hemangioma," "cavernoma," "surgery," and "resection." References from all selected papers were further examined for additional suitable studies and to identify possible patient duplication. We selected only those reports of patients harboring supratentorial CCMs causing preoperative seizures, in which postoperative seizure status was a primary outcome and the follow-up spanned a minimum of 6 months for all patients. Studies were excluded if they included fewer than 5 patients, reported only redundant data, did not disaggregate seizure outcomes, were not written in English, or consisted of a review. Studies that considered lesions other than CCMs or examined infratentorial lesions were included in part only if the outcomes related to other lesion types could be excluded. Outcomes from all studies were disaggregated across 12 variables where possible: 1) patient age at surgery (< 18 vs ≥ 18 years old); 2) sex; 3) CCM location (temporal lobe vs extratemporal); 4) CCM laterality; 5) CCM size (maximum diameter < 1.5 vs ≥ 1.5 cm); 6) CCM multiplicity (resection of solitary vs multiple lesions); 7) preoperative seizure control on medication (controlled vs refractory); 8) seizure semiology (partial seizures only vs secondarily generalized seizures); 9) duration of epilepsy before surgery (≤ 1 vs > 1 year); 10) extent of resection (gross total vs subtotal); 11) whether perilesional hemosiderin-stained parenchyma was excised (lesionectomy only vs additional corticectomy); and 12) whether awake ECoG was used intraoperatively. Cerebral cavernous malformation size was dichotomized at 1.5 cm because prior evidence has suggested a more favorable postoperative seizure outcome with lesions below this size.
12 Gross-total resection was defined based on the lack of residual lesion both intraoperatively and on postoperative imaging. Seizure outcomes were defined using the Engel classification scheme.
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Statistical Analysis
Separate meta-analyses were performed on calculated pooled rates of seizure freedom (Engel Class I) versus persistent seizures (Engel Class II-IV) for each variable. Initial between-group comparisons were performed using the Pearson chi-square test. Binary logistic regression analysis was then used to evaluate the variables found to be significant on chi-square testing by using a backward stepwise approach. Odds ratios were calculated with a 95% confidence interval. The Friedman test and Kendall W test were used to analyze data heterogeneity between studies to ensure that a fixed-effects model was appropriate, and the Cox and Snell R-squared values were calculated to ensure goodness-of-fit of the applied model. The Begg funnel plot method was applied to detect the possible effect of publication bias. Missing values were addressed by listwise deletion, and multiple imputation was not used. Given the number of comparisons being made, the level of significance was set at 0.02 for all analyses. Statistical analysis was performed using SPSS version 17 software (SPSS, Inc.).
Results
We identified 1226 patients across 31 studies on seizure control following the resection of supratentorial CCMs. Three studies identified on initial query were excluded because of a sample size smaller than 5 patients, the lack of seizure outcome disaggregation, or data redundancy, respectively. All included papers were retrospective analyses, except for one prospective observational study, and are listed in Table  1 . No controlled trials of seizure outcomes in CCM resection were identified. All patients had experienced lesionrelated seizures preoperatively and were followed up for at least 6 months after surgery, with a mean follow-up ranging from > 12 to 97 months within the individual studies. Across individual data sets, 33%-100% of patients were seizure free after resection, as summarized in Fig. 1 . Overall, 915 patients (75%) were free of seizures after surgery (Engel Class I), whereas 311 (25%) continued to have seizures (Engel Classes II-IV).
Seizure outcomes were stratified across 12 variables of interest where disaggregation was possible, as summarized in Table 2 . We first looked at patient demographics and observed similar rates of postoperative seizure freedom among pediatric versus adult patients (75% vs 73% seizure free, respectively) and among female versus male patients (71% each). Next, we examined factors related to the lesion. There was no statistical difference in seizure outcomes between patients with temporal lobe versus extratemporal CCMs, nor with left versus right hemispheric lesions. However, we did find that individuals with smaller (< 1.5 cm) CCMs attained a dramatically higher seizure control rate (86%) than did those with a lesion size ≥ 1.5 cm (29% seizure free; p < 0.001). Resection of a solitary CCM was also predictive of a favorable outcome: while 71% of those with a solitary lesion became seizure free after surgery, only 55% of those with multiple resected CCMs attained this outcome (p < 0.02).
We next analyzed whether characteristics related to epilepsy predicted the postoperative seizure status. It was noted that individuals with preoperative seizures controlled with AEDs attained a higher rate of seizure freedom after CCM resection (84%) than did those with medically refractory epilepsy (69%; p < 0.01; Table 2 ). Seizure semiology also predicted variable outcomes, as 81% of patients experiencing only partial seizures became seizure free postoperatively, compared with only 56% of individuals with secondarily generalized events (p < 0.001). Furthermore, a shorter preoperative history of seizures (≤ 1 year) prognosticated a better result (81% seizure freedom) than did a longer history (> 1 year) of epilepsy (p < 0.001).
Finally, factors related to surgical intervention were examined for possible outcome prognostication. Gross-total lesionectomy resulted in a dramatically better chance of seizure control (77%) than did subtotal CCM resection, after which only 8% of patients were seizure free (p < 0.001; Table 2 ). However, patients were equally likely to stop seizing after undergoing lesionectomy with or without additional excision of surrounding hemosiderin fringe (75% vs 76% seizure free, respectively). In determining whether intraoperative ECoG affected outcome, we noted that its use led to a somewhat higher rate of seizure freedom (78%) than did surgery without ECoG (68%), but this difference did not reach our threshold for statistical significance (p = 0.03).
Binary logistic regression analyses were used to further scrutinize the 6 variables found to be statistically significant on chi-square testing, as summarized in Table 3 . A CCM size < 1.5 cm and a solitary lesion significantly predicted postoperative seizure freedom, with odds ratios 
Discussion
Seizures are the most common presenting symptom in patients with supratentorial CCMs and can progress to medically refractory epilepsy in approximately 40% of cases. 13, 37, 44 While most studies of CCMs focus on the risk of intracranial hemorrhage, eliminating the seizure burden in patients with cavernoma and epilepsy can reduce disability and improve quality of life, and thus is an important goal of treatment. To identify the epidemiological and therapeutic predictors of seizure freedom in the resection of supratentorial CCMs, we performed a systematic literature review of 1226 CCM patients with lesionrelated seizures and stratified the seizure outcomes across various potentially prognostic variables. Overall, 75% of patients became seizure free after resection, suggesting that a microsurgical approach often leads to a favorable outcome but also indicating considerable room for improvement. Most importantly, we found that potentially modifiable predictors of postoperative seizure control included both GTR (vs subtotal lesionectomy) and a shorter preoperative history of epilepsy (≤ 1 year). These factors reveal that achieving a gross-total lesionectomy and early intervention are important goals in cases in which resection is deemed as an appropriate and safe treatment for a CCM. Gross-total resection can be challenging in deep or eloquent brain regions, but various microsurgical approaches and trajectories have been recently described to facilitate safe access to supratentorial CCMs in these locations. 12 Finally, our finding that patients with larger CCMs (≥ 1.5 cm) continued to seize more often than those with smaller lesions (< 1.5 cm) also supports early surgical treatment, as some cavernomas have demonstrated the potential to grow in size over time. 32, 40, 45 One controversy in the operative treatment of supratentorial CCMs is whether to excise the hemosiderinstained parenchyma surrounding the lesion. Some groups have reported improved seizure outcomes with an extended lesionectomy including the hemosiderin ring, 6, 28, 49 whereas others have demonstrated no additional benefit over pure lesionectomy.
56,57 Overall, we found no difference in the rates of seizure freedom after pure lesionectomy versus inclusion of the hemosiderin fringe. This finding suggests that a more extensive resection beyond gross-total lesionectomy may not confer any additional benefit in seizure control but may be associated with increased neurological morbidity. Given the conflicting findings in previous reports, however, additional prospective data should be sought to further clarify this issue.
Not surprisingly, it was also noted that a greater disease burden was associated with higher rates of postoperative seizures. Patients with multiple CCMs were less likely to attain seizure freedom after resection than were those who had harbored a single cavernoma. Moreover, both the presence of secondarily generalized seizures and poor seizure control on AEDs predicted a worse outcome. In mesial temporal lobe epilepsy, the most common form of epilepsy, secondary generalization has been associated with postoperative seizure recurrence, 30, 31, 36 and the presence of generalized seizures has been linked to more significant mesial temporal atrophy. 11, 17 It is therefore plausible that CCM patients with more severe epileptic events have higher rates of dual pathology, 25,48 which may continue to drive seizures after lesionectomy. More evidence will be needed to further evaluate this possibility.
No differences in seizure outcome were observed in adults versus children, males versus females, or with cavernomas located in the left versus the right hemisphere or the temporal lobe versus the extratemporal region. Finally, the use of intraoperative ECoG was associated with a 10% higher rate of postoperative seizure control, but this difference was not significant. Note, however, that it is not known whether cases in which ECoG is used are associated a priori with more severe epilepsy or with a lesion less amenable to GTR given the involvement of eloquent structures, and thus potentially confounding this result. Furthermore, insufficient data were available to specifically investigate whether ECoG might be of varied benefit in patients with medically refractory versus controlled epilepsy. Prospective investigations with comparable patient characteristics will be needed to further address the benefit of intraoperative ECoG for epilepsy related to CCMs.
There are several limitations to the present systematic review. While these data represent a useful summary of seizure control following supratentorial CCM resec- tion in a large patient population, they are limited by the quality of the data published by others. We cannot ascertain the validity of subjectively defined variables reported in the original articles, which may have an important influence on our findings. All except one of the analyzed papers featured retrospective uncontrolled studies, and 3 articles included fewer than 10 patients, introducing the possibility of bias in result reporting and interpretation. Moreover, the exclusion of non-English papers may lead to the omission of useful data. As no controlled trials of seizure outcome in CCM resection have been performed to our knowledge, this study cannot be considered a formal meta-analysis of trial data, but rather is a systematic review of available literature. While a single, large prospective series with post hoc testing of potential interactions would certainly be welcomed, the strength of the present evaluation lies in the ability to pool a large number of cases, which would be difficult to achieve even in a multiinstitutional trial. Finally, many interesting issues were not addressed in our study, such as a comparative evaluation of microsurgery versus stereotactic radiosurgery to treat CCMs causing seizures, but will certainly contribute to excellent questions in future investigations.
Conclusions
In summary, CCMs are vascular brain lesions that most commonly appear with seizures and often result in medically refractory epilepsy. In a systematic review of 1226 patients with supratentorial CCMs, we found that early operative intervention and GTR significantly improved seizure outcome. Individuals with a single lesion and smaller lesions, as well as those with pharmacologically controlled epilepsy and the absence of secondarily generalized events, were also more likely to attain postoperative seizure freedom. Resection should not be considered a first-line treatment for CCM-related epilepsy, because seizures can often be controlled with AEDs, and because many patients are not good surgical candidates. However, given the considerable effects that epilepsy can have on a patient's quality of life, it is critical to understand the demographic and treatment variables associated with seizure control in CCM resection and to incorporate that knowledge into our neurosurgical practices and patient discussions.
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